Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5866_Библиотеки_им_академика_М_И_Перельмана
.pdf
186 Xuan Mu and Yu Shrike Zhang
[16] Lee JN, Park C, Whitesides GM. Solvent compatibility of poly(dimethylsiloxane)-based microfluidic
devices. Anal Chem 2003;75(23):6544–54.
[17] Whitesides GM, Ostuni E, Takayama S, Jiang XY, Ingber DE. Soft lithography in biology and bio-
chemistry. Annu Rev Biomed Eng 2001;3:335–73.
[18] Qin D, Xia Y, Whitesides GM. Soft lithography for micro- and nanoscale patterning. Nat Protoc
2010;5(3):491–502.
[19] Unger MA, Chou HP, Thorsen T, Scherer A, Quake SR. Monolithic microfabricated valves and
pumps by multilayer soft lithography. Science 2000;288(5463):113–6.
[20] Quake SR, Scherer A. From micro- to nanofabrication with soft materials. Science 2000;290
(5496):1536–40.
[21] Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting
organ-level lung functions on a chip. Science 2010;328(5986):1662–8.
[22] Ribas J, Zhang YS, Pitrez PR, Leijten J, Miscuglio M, Rouwkema J, Dokmeci MR, Nissan X,
Ferreira L, Khademhosseini A. Biomechanical strain exacerbates inflammation on a progeria-ona-chip model. Small 2017;13(15):1603737.
[23] Liu J, Hwang HH, Wang P, Whang G, Chen S. Direct 3D-printing of cell-laden constructs in micro-
fluidic architectures. Lab Chip 2016;16:1430–8.
[24] Homan KA, Kolesky DB, Skylar-Scott MA, Herrmann J, Obuobi H, Moisan A, Lewis JA. Bio-
printing of 3D convoluted renal proximal tubules on perfusable chips. Sci Rep 2016;6:34845.
[25] Ho CMB, Ng SH, Li KHH, Yoon Y-J. 3D printed microfluidics for biological applications. Lab Chip
2015;15(18):3627–37.
[26] Au AK, Huynh W, Horowitz LF, Folch A. 3D-printed microfluidics. Angew Chem Int Ed 2016;55
(12):3862–81.
[27] Ling Y, Rubin J, Deng Y, Huang C, Demirci U, Karp JM, Khademhosseini A. A cell-laden micro-
fluidic hydrogel. Lab Chip 2007;7(6):756–62.
[28] Mu X, Zheng W, Xiao L, Zhang W, Jiang X. Engineering a 3D vascular network in hydrogel for
mimicking a nephron. Lab Chip 2013;13(8):1612–8.
[29] Baker BM, Trappmann B, Stapleton SC, Toro E, Chen CS. Microfluidics embedded within extra-
cellular matrix to define vascular architectures and pattern diffusive gradients. Lab Chip 2013;13
(16):3246–52.
[30] Ren K, Zhou J, Wu H. Materials for microfluidic chip fabrication. Acc Chem Res 2013;46
(11):2396–406.
[31] Sun W, Luo Z, Lee J, Kim HJ, Lee K, Tebon P, Feng Y, Dokmeci MR, Sengupta S, Khademhosseini
A. Organ-on-a-chip for cancer and immune organs modeling. Adv Healthc Mater 2019;8
(4):1801363.
[32] Chen X, Zhang YS, Zhang X, Liu C. Organ-on-a-chip platforms for accelerating the evaluation of
nanomedicine. Bioact Mater 2020;6(4):1012–27.
[33] Zhang YS, Aleman J, Shin SR, Kilic T, Kim D, Shaegh SAM, Massa S, Riahi R, Chae S, Hu N.
Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring
of organoid behaviors. Proc Natl Acad Sci 2017;114(12):E2293–302.
[34] Zhang Y. The ultimate in personalized medicine: your body on a chip. In: IEEE spectrum. IEEE;
2019.
[35] Maharjan S, Cecen B, Zhang YS. 3D immunocompetent organ-on-a-chip models. Small Methods
2020;4(9):2000235.
[36] Yesil-Celiktas O, Hassan S, Miri AK, Maharjan S, Al-kharboosh R, Quin˜ones-Hinojosa A, Zhang
YS. Mimicking human pathophysiology in organ-on-Chip devices. Adv Biosyst 2018;2(10):1800109.
[37] Sharifi F, Yesil-Celiktas O, Kazan A, Maharjan S, Saghazadeh S, Firoozbakhsh K, Firoozabadi B,
Zhang YS. A hepatocellular carcinoma
–bone
metastasis-on-a-chip model for studying
thymoquinone-loaded anticancer nanoparticles. In: Bio-design and manufacturing; 2020.
[38] Zhang YS, Zhang Y-N, Zhang W. Cancer-on-a-chip systems at the frontier of nanomedicine. Drug
Discov Today 2017;22(9):1392–9.
[39] Zhang YS, Khademhosseini A. Engineering in vitro human tissue models through bio-design and
manufacturing. Springer; 2020.
[40] Palchesko RN, Zhang L, Sun Y, Feinberg AW. Development of polydimethylsiloxane substrates with
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
tunable elastic modulus to study cell mechanobiology in muscle and nerve. PLoS ONE 2012;7(12),
e51499.
[41] Johnston I, McCluskey D, Tan C, Tracey M. Mechanical characterization of bulk Sylgard 184 for
microfluidics and microengineering. J Micromech Microeng 2014;24(3), 035017.
[42] Zhou JH, Yan H, Ren KN, Dai W, Wu HK. Convenient method for modifying
poly(dimethylsiloxane) with poly(ethylene glycol) in microfluidics. Anal Chem 2009;81
(16):6627–32.
[43] Choi NW, Cabodi M, Held B, Gleghorn JP, Bonassar LJ, Stroock AD. Microfluidic scaffolds for tissue
engineering. Nat Mater 2007;6(11):908–15.
[44] Ren KN, Liang QL, Yao B, Luo GO, Wang LD, Gao Y, Wang YM, Qiu Y. Whole column fluo-
rescence imaging on a microchip by using a programmed organic light emitting diode array as a spatial-
scanning light source and a single photomultiplier tube as detector. Lab Chip 2007;7(11):1574–80.
[45] Sun H, Chan C-W, Wang Y, Yao X, Mu X, Lu X, Zhou J, Cai Z, Ren K. Reliable and reusable
whole polypropylene plastic microfluidic devices for a rapid, low-cost antimicrobial susceptibility test.
Lab Chip 2019;19(17):2915–24.
[46] Ren K, Chen Y, Wu H. New materials for microfluidics in biology. Curr Opin Biotechnol
2014;25:78–85.
[47] Cera L, Gonzalez GM, Liu Q, Choi S, Chantre CO, Lee J, Gabardi R, Choi MC, Shin K, Parker KK.
A bioinspired and hierarchically structured shape-memory material. Nat Mater 2020;1–8.
[48] Alsharhan AT, Acevedo R, Warren R, Sochol RD. 3D microfluidics via cyclic olefin polymer-based
in situ direct laser writing. Lab Chip 2019;19(17):2799–810.
[49] Ching T, Li Y, Karyappa R, Ohno A, Toh Y-C, Hashimoto M. Fabrication of integrated microfluidic
devices by direct ink writing (DIW) 3D printing. Sens Actuators B 2019;297:126609.
[50] Lee Y-S, Bhattacharjee N, Folch A. 3D-printed Quake-style microvalves and micropumps. Lab Chip
2018;18(8):1207–14.
[51] Naderi A, Bhattacharjee N, Folch A. Digital manufacturing for microfluidics. Annu Rev Biomed Eng
2019;21:325–64.
[52] Bhattacharjee N, Parra-Cabrera C, Kim YT, Kuo AP, Folch A. Desktop-Stereolithography
3D-printing of a poly (dimethylsiloxane)-based material with Sylgard-184 properties. Adv Mater
2018;30(22):1800001.
[53] Kuo AP, Bhattacharjee N, Lee YS, Castro K, Kim YT, Folch A. High-precision stereolithography of
biomicrofluidic devices. Adv Mater Technol 2019;4(6):1800395.
[54] Kim YT, Bohjanen S, Bhattacharjee N, Folch A. Partitioning of hydrogels in 3D-printed micro-
channels. Lab Chip 2019;19(18):3086–93.
[55] Zhang YS, Khademhosseini A. Advances in engineering hydrogels. Science 2017;356(6337),
eaaf3627.
[56] Gong J, Schuurmans CC, van Genderen AM, Cao X, Li W, Cheng F, He JJ, Lo´pez A, Huerta V,
Manrı´quez J. Complexation-induced resolution enhancement of 3D-printed hydrogel constructs.
Nat Commun 2020;11(1):1–14.
[57] Kolesky DB, Homan KA, Skylar-Scott MA, Lewis JA. Three-dimensional bioprinting of thick vas-
cularized tissues. Proc Natl Acad Sci 2016;113(12):3179–84.
[58] Kolesky DB, Truby RL, Gladman A, Busbee TA, Homan KA, Lewis JA. 3D bioprinting of vascu-
larized, heterogeneous cell-laden tissue constructs. Adv Mater 2014;26(19):3124–30.
[59] Hasan A, Paul A, Memic A, Khademhosseini A. A multilayered microfluidic blood vessel-like struc-
ture. Biomed Microdevices 2015;17(5):88.
[60] Mu X, Wang Y, Guo C, Li Y, Ling S, Huang W, Cebe P, Hsu HH, De Ferrari F, Jiang X, Xu Q,
Balduini A, Omenetto F, Kaplan DL. 3D printing of silk protein structures by aqueous solvent-
directed molecular assembly. Macromol Biosci 2020;20:1900191.
[61] Squires TM, Quake SR. Microfluidics: fluid physics at the nanoliter scale. Rev Mod Phys 2005;77
(3):977–1026.
[62] Garstecki
microfluidic T-junction – scaling and mechanism of break-up. Lab Chip 2006;6(3):437–46.
[63] Utada AS, Lorenceau E, Link DR, Kaplan PD, Stone HA, Weitz DA. Monodisperse double emul-
sions generated from a microcapillary device. Science 2005;308(5721):537–41.
P, Fuerstman MJ, Stone HA, Whitesides GM. Formation of droplets and bubbles in a
187Tumor-on-a-chip devices for cancer immunotherapy
188 Xuan Mu and Yu Shrike Zhang
[64] Mao XL, Waldeisen JR, Huang TJ. “Microfluidic drifting” – implementing three-dimensional
hydrodynamic focusing with a single-layer planar microfluidic device. Lab Chip 2007;7(10):1260–2.
[65] Mu X, Liang Q, Zhou J, Ren K, Hu P, Wang Y, Zheng Z, Luo G. Oil–water biphasic parallel flow for
the precise patterning of metals and cells. Biomed Microdevices 2014;16:245–53.
[66] Mu X, Liang QL, Hu P, Ren KN, Wang YM, Luo GA. Laminar flow used as “liquid etch mask” in
wet chemical etching to generate glass microstructures with an improved aspect ratio. Lab Chip
2009;9(14):1994–6.
[67] Kenis PJA, Ismagilov RF, Takayama S, Whitesides GM, Li SL, White HS. Fabrication inside micro-
channels using fluid flow. Acc Chem Res 2000;33(12):841–7.
[68] Chiu DT, Jeon NL, Huang S, Kane RS, Wargo CJ, Choi IS, Ingber DE, Whitesides GM. Patterned
deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems. Proc
Natl Acad Sci U S A 2000;97(6):2408–13.
[69] Aota A, Nonaka M, Hibara A, Kitamori T. Countercurrent laminar microflow for highly efficient
solvent extraction. Angew Chem Int Ed 2007;46(6):878–80.
[70] Mu X, Liang Q, Hu P, Ren K, Wang Y, Luo G. Selectively modified microfluidic chip for solvent
extraction of radix salvia miltiorrhiza using three-phase laminar flow to provide double liquid-liquid
interface area. Microfluid Nanofluid 2010;9(2–3):365– 73.
[71] Choban ER, Markoski LJ, Wieckowski A, Kenis PJA. Microfluidic fuel cell based on laminar flow.
J Power Sources 2004;128(1):54–60.
[72] Asghar W, El Assal R, Shafiee H, Pitteri S, Paulmurugan R, Demirci U. Engineering cancer micro-
environments for in vitro 3-D tumor models. Mater Today 2015;18(10):539–53.
[73] Joanicot M, Ajdari A. Droplet control for microfluidics. Science 2005;309(5736):887–8.
[74] Teh SY, Lin R, Hung LH, Lee AP. Droplet microfluidics. Lab Chip 2008;8(2):198–220.
[75] Zheng B, Tice JD, Ismagilov RF. Formation of droplets of in microfluidic channels alternating com-
position and applications to indexing of concentrations in droplet-based assays. Anal Chem 2004;76
(17):4977–82.
[76] Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science
2015;348(6230):74–80.
[77] Adriani G, Pavesi A, Tan AT, Bertoletti A, Thiery JP, Kamm RD. Microfluidic models for adoptive
cell-mediated cancer immunotherapies. Drug Discov Today 2016;21(9):1472–8.
[78] Schaaf MB, Garg AD, Agostinis P. Defining the role of the tumor vasculature in antitumor immunity
and immunotherapy. Cell Death Dis 2018;9(2):115.
[79] Dangles V, Validire P, Wertheimer M, Richon S, Bovin C, Zeliszewski D, Vallancien G, Bellet D.
Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation. Int
J Cancer 2002;98(1):51–6.
[80] Feder-Mengus C, Ghosh S, Reschner A, Martin I, Spagnoli GC. New dimensions in tumor immu-
nology: what does 3D culture reveal? Trends Mol Med 2008;14(8):333–40.
[81] Busse A, Letsch A, Fusi A, Nonnenmacher A, Stather D, Ochsenreither S, Regenbrecht CR, Keilholz
U. Characterization of small spheres derived from various solid tumor cell lines: are they suitable tar-
gets for T cells? Clin Exp Metastasis 2013;30(6):781–91.
[82] Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK. Method for generation of homo-
geneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng
2003;83(2):173–80.
[83]
Tu T-Y, Wang Z, Bai J, Sun W, Peng WK, Huang RY-J, Thiery J-P, Kamm RD. Rapid prototyping
concave microwells for the formation of 3D multicellular cancer aggregates for drug screening. Adv
of
Healthc Mater 2014;3(4):609–16.
[84] Alessandri K, Sarangi BR, Gurchenkov VV, Sinha B, Kießling TR, Fetler L, Rico F, Scheuring S,
Lamaze C, Simon A, Geraldo S, Vignjevic D, Domejean H, Rolland L, Funfak A, Bibette J, Bremond
N, Nassoy P. Cellular capsules as a tool for multicellular spheroid production and for investigating the
mechanics of tumor progression in vitro. Proc Natl Acad Sci 2013;110(37):14843–8.
[85] Chen R, Dong Y, Xie X, Chen J, Gao D, Liu Y, Ren Z, Cui J. Screening candidate metastasis-
associated genes in three-dimensional HCC spheroids with different metastasis potential. Int J Clin
Exp Pathol 2014;7(5):2527.
[86] Cekanova M, Rathore K. Animal models and therapeutic molecular targets of cancer: utility and lim-
itations. Drug Des Dev Ther 2014;8:1911.
[87] Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
response. Nature 2013;501(7467):346–54.
[88] Plaks V, Koopman CD, Werb Z. Circulating tumor cells. Science 2013;341(6151):1186–8.
[89] Kim C, Kasuya J, Jeon J, Chung S, Kamm RD. A quantitative microfluidic angiogenesis screen for
studying anti-angiogenic therapeutic drugs. Lab Chip 2015;15(1):301–10.
[90] Paramore A, Frantz S. Bortezomib. Nat Rev Drug Discov 2003;2(8):611–2.
[91] Ko J, Ahn J, Kim S, Lee Y, Lee J, Park D, Jeon NL. Tumor spheroid-on-a-chip: a standardized micro-
fluidic culture platform for investigating tumor angiogenesis. Lab Chip 2019;19(17):2822–33.
[92] Berthier E, Young EWK, Beebe D. Engineers are from PDMS-land, biologists are from polystyrenia.
Lab Chip 2012;12(7):1224–37.
[93] Toepke MW, Beebe DJ. PDMS absorption of small molecules and consequences in microfluidic
applications. Lab Chip 2006;6(12):1484–6.
[94] Fennema E, Rivron N, Rouwkema J, van Blitterswijk C, De Boer J. Spheroid culture as a tool for
creating 3D complex tissues. Trends Biotechnol 2013;31(2):108–15.
[95] Costa EC, Moreira AF, de Melo-Diogo D, Gaspar VM, Carvalho MP, Correia IJ. 3D tumor spher-
oids: an overview on the tools and techniques used for their analysis. Biotechnol Adv 2016;34
(8):1427–41.
[96] Zhu Y, Zhang Y-X, Cai L-F, Fang Q. Sequential operation droplet array: an automated microfluidic
platform for Picoliter-scale liquid handling, analysis, and screening. Anal Chem 2013;85(14):6723–31.
[97] Du X, Li W, Du G, Cho H, Yu M, Fang Q, Lee LP, Fang J. Droplet array-based 3D coculture system
for high-throughput tumor angiogenesis assay. Anal Chem 2018;90(5):3253–61.
[98] Malda J, Klein TJ, Upton Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng
2007;13(9):2153–62.
[99] Igarashi J, Erwin PA, Dantas APV, Chen H, Michel T. VEGF induces S1P1 receptors in endothelial
cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci
2003;100(19):10664–9.
[100] Owen SC, Doak AK, Ganesh AN, Nedyalkova L, McLaughlin CK, Shoichet BK, Shoichet MS. Col-
loidal drug formulations can explain “bell-shaped” concentration–response curves. ACS Chem Biol
2014;9(3):777–84.
[101] Reymond N, d’A´gua BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev
Cancer 2013;13(12):858–70.
[102] Galluzzi L, Chan TA, Kroemer G, Wolchok JD, Lo´pez-Soto A. The hallmarks of successful anticancer
immunotherapy. Sci Transl Med 2018;10(459), eaat7807.
[103] Ma Y-HV, Middleton K, You L, Sun Y. A review of microfluidic approaches for investigating cancer
extravasation during metastasis. Microsyst Nanoeng 2018;4(1):1–13.
[104] Coughlin MF, Kamm RD. The use of microfluidic platforms to probe the mechanism of cancer cell
extravasation. Adv Healthc Mater 2020;9(8):1901410.
[105] Mondadori C, Crippa M, Moretti M, Candrian C, Lopa S, Arrigoni C. Advanced microfluidic models
of cancer and immune cell extravasation: a systematic review of the literature. Front Bioeng Bio-
technol 2020;8:907.
[106] Kim Y, Williams KC, Gavin CT, Jardine E, Chambers AF, Leong HS. Quantification of cancer cell
extravasation in vivo. Nat Protoc 2016;11(5):937.
[107] Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, Kamm RD. Three-
dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc
Natl Acad Sci 2012;109(34):13515–20.
[108] Albini
[109] Stoletov K, Kato H, Zardouzian E, Kelber J, Yang J, Shattil S, Klemke R. Visualizing extravasation
[110] Chen MB, Whisler JA, Jeon JS, Kamm RD. Mechanisms of tumor cell extravasation in an in vitro
[111] Al-Mehdi A, Tozawa K, Fisher A, Shientag L, Lee A, Muschel R. Intravascular origin of metastasis
A, Noonan DM. The ‘chemoinvasion’ assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis. Curr Opin Cell Biol
2010;22(5):677–89.
dynamics of metastatic tumor cells. J Cell Sci 2010;123(13):2332–41.
microvascular network platform. Integr Biol 2013;5(10):1262–71.
from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med
2000;6(1):100–2.
189Tumor-on-a-chip devices for cancer immunotherapy
190 Xuan Mu and Yu Shrike Zhang
[112] Jeon JS, Zervantonakis IK, Chung S, Kamm RD, Charest JL. In vitro model of tumor cell extrava-
sation. PLoS ONE 2013;8(2), e56910.
[113] Jeon JS, Bersini S, Gilardi M, Dubini G, Charest JL, Moretti M, Kamm RD. Human 3D vascularized
organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci 2015;112
(1):214–9.
[114] Parlakian A, Gomaa I, Solly S, Arandel L, Mahale A, Born G, Marazzi G, Sassoon D. Skeletal muscle
phenotypically converts and selectively inhibits metastatic cells in mice. PLoS One 2010;5(2), e9299.
[115] Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, Harish A, Merimski O,
Barer F, Fishman P. The A3 adenosine receptor is highly expressed in tumor versus normal cells:
potential target for tumor growth inhibition. Clin Cancer Res 2004;10(13):4472–9.
[116] Boussommier-Calleja A, Atiyas Y, Haase K, Headley M, Lewis C, Kamm R. The effects of monocytes
on tumor cell extravasation in a 3D vascularized microfluidic model. Biomaterials 2019;198:180–93.
[117] Hajal C, Ibrahim L, Serrano JC, Offeddu GS, Kamm RD. The effects of luminal and trans-endothelial
fluid flows on the extravasation and tissue invasion of tumor cells in a 3D in vitro microvascular platform. Biomaterials 2020;265:120470.
[118] Kawamata H, Kawai K, Kameyama S, Johnson MD, Stetler-Stevenson WG, Oyasu R. Over-
expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int J Cancer 1995;63(5):680–7.
[119] Hanna RN, Cekic C, Sag D, Tacke R, Thomas GD, Nowyhed H, Herrley E, Rasquinha N, McArdle
S, Wu R, Peluso E, Metzger D, Ichinose H, Shaked I, Chodaczek G, Biswas SK, Hedrick CC. Patrolling monocytes control tumor metastasis to the lung. Science 2015;350(6263):985–90.
[120] Stein JV, Nombela-Arrieta C. Chemokine control of lymphocyte trafficking: a general overview.
Immunology 2005;116(1):1–12.
[121] Da Silva RB, Laird ME, Yatim N, Fiette L, Ingersoll MA, Albert ML. Dipeptidylpeptidase 4 inhibi-
tion enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and
immunotherapy. Nat Immunol 2015;16(8):850–8.
[122] Sackstein R, Schatton T, Barthel SR. T-lymphocyte homing: an underappreciated yet critical hurdle
for successful cancer immunotherapy. Lab Invest 2017;97(6):669–97.
[123] Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF. Che-
mokine expression in melanoma metastases associated with CD8 + T-cell recruitment. Cancer Res
2009;69(7):3077–85.
[124] Li J, Lin F. Microfluidic devices for studying chemotaxis and electrotaxis. Trends Cell Biol 2011;21
(8):489–97.
[125] Kim S, Kim HJ, Jeon NL. Biological applications of microfluidic gradient devices. Integr Biol 2010;2
(11 12):584–603.
[126] Jeon NL, Baskaran H, Dertinger SKW, Whitesides GM, Van de Water L, Toner M. Neutrophil che-
motaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol 2002;20(8):826–30.
[127] Henkels KM, Frondorf K, Gonzalez-Mejia ME, Doseff AL, Gomez-Cambronero J. IL-8-induced
neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3). FEBS Lett 2011;585(1):159–66.
[128] Wu HK, Huang B, Zare RN. Generation of complex, static solution gradients in microfluidic chan-
nels. J Am Chem Soc 2006;128(13):4194–5.
[129] Chen H-C. Boyden chamber assay. In: Cell migration. Springer; 2005. p. 15–22.
[130] Muinonen-Martin AJ, Veltman DM, Kalna G, Insall RH. An improved chamber for direct visuali-
sation of chemotaxis. PLoS ONE 2010;5(12), e15309.
[131] Zhao W, Zhao H, Li M, Huang C. Microfluidic devices for neutrophil chemotaxis studies. J Transl
Med 2020;18:1–19.
[132] Grigolato F, Egholm C, Impellizzieri D, Arosio P, Boyman O. Establishment of a scalable microfluidic
assay for characterization of population-based neutrophil chemotaxis. Allergy 2020;75(6):1382
[133] Lin
F, Butcher EC. T cell chemotaxis in a simple microfluidic device. Lab Chip 2006;6(11):1462–9.
–93.
[134] Jenkins RW, Barbie DA, Flaherty KT. Mechanisms of resistance to immune checkpoint inhibitors. Br
J Cancer 2018;118(1):9–16.
[135] Letai A. Functional precision cancer medicine—moving beyond pure genomics. Nat Med 2017;23
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
(9):1028.
[136] Deng J, Wang ES, Jenkins RW, Li S, Dries R, Yates K, Chhabra S, Huang W, Liu H, Aref AR.
CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation. Cancer Discov
2018;8(2):216–33.
[137] Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H,
Miao D. Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids. Cancer Discov
2018;8(2):196–215.
[138] Aref AR, Campisi M, Ivanova E, Portell A, Larios D, Piel BP, Mathur N, Zhou C, Coakley RV,
Bartels A. 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade. Lab Chip 2018;18(20):3129–43.
[139] Horowitz LF, Rodriguez AD, Dereli-Korkut Z, Lin R, Castro K, Mikheev A, Monnat RJ, Folch A,
Rostomily RC. Multiplexed drug testing of tumor slices using a microfluidic platform. NPJ Precis
Oncol 2020;4(1):1–15.
[140] Horowitz LF, Rodriguez AD, Au-Yeung A, Bishop KW, Barner LA, Mishra G, Raman A, Delgado
P, Liu JT, Gujral TS. Microdissected “cuboids” for microfluidic drug testing of intact tissues. Lab Chip
2020. https://doi.org/10.1039/d0lc00801j.
[141] Pourmand A, Shaegh SAM, Ghavifekr HB, Aghdam EN, Dokmeci MR, Khademhosseini A, Zhang
YS. Fabrication of whole-thermoplastic normally closed microvalve, micro check valve, and micropump. Sens Actuators B 2018;262:625–36.
[142] Shaegh SAM, Pourmand A, Nabavinia M, Avci H, Tamayol A, Mostafalu P, Ghavifekr HB, Aghdam
EN, Dokmeci MR, Khademhosseini A. Rapid prototyping of whole-thermoplastic microfluidics
with built-in microvalves using laser ablation and thermal fusion bonding. Sens Actuators
B 2018;255:100–9.
[143] Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani M,
Brijwani N, Pinto DD, Prasath A, Shanthappa BU. Predicting clinical response to anticancer drugs
using an ex vivo platform that captures tumour heterogeneity. Nat Commun 2015;6(1):1–14.
[144] Miller JF, Sadelain M. The journey from discoveries in fundamental immunology to cancer immu-
notherapy. Cancer Cell 2015;27(4):439–49.
[145] Mandal PK, Ferreira LM, Collins R, Meissner TB, Boutwell CL, Friesen M, Vrbanac V, Garrison BS,
Stortchevoi A, Bryder D. Efficient ablation of genes in human hematopoietic stem and effector cells
using CRISPR/Cas9. Cell Stem Cell 2014;15(5):643–52.
[146] Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev
Genet 2007;8(8):573–87.
[147] Hu Y-C. Baculoviral vectors for gene delivery: a review. Curr Gene Ther 2008;8(1):54–65.
[148] Wagner H. Toll meets bacterial CpG-DNA. Immunity 2001;14(5):499–502.
[149] Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H,
Takeda K. A toll-like receptor recognizes bacterial DNA. Nature 2000;408(6813):740 –5.
[150] Slowing II, Trewyn BG, Lin VS-Y. Mesoporous silica nanoparticles for intracellular delivery of
membrane-impermeable proteins. J Am Chem Soc 2007;129(28):8845–9.
[151] Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen Z-Y,
Liu DR. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing
in vitro and in vivo. Nat Biotechnol 2015;33(1):73–80.
[152] Gao X, Tao Y, Lamas V, Huang M, Yeh W-H, Pan B, Hu Y-J, Hu JH, Thompson DB, Shu Y.
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature
2018;553(7687):217–21.
[153] Ramakrishna S, Dad A-BK, Beloor J, Gopalappa R, Lee S-K, Kim H. Gene disruption by cell-
penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res 2014;24
(6):1020–7.
[154] Heller LC, Heller R. Electroporation gene therapy preclinical and clinical trials for melanoma. Curr
Gene Ther 2010;10(4):312
[155] Lentacker
sonoporation: definitions and underlying mechanisms. Adv Drug Deliv Rev 2014;72:49–64.
I, De Cock I, Deckers R, De Smedt S, Moonen C. Understanding ultrasound induced
–7.
191Tumor-on-a-chip devices for cancer immunotherapy
192 Xuan Mu and Yu Shrike Zhang
[156] Lin S, Staahl BT, Alla RK, Doudna JA. Enhanced homology-directed human genome engineering by
controlled timing of CRISPR/Cas9 delivery. elife 2014;3, e04766.
[157] Meaking W, Edgerton J, Wharton C, Meldrum R. Electroporation-induced damage in mammalian
cell DNA. Biochim Biophys Acta 1995;1264(3):357–62.
[158] Zhang Y, Yu L-C. Microinjection as a tool of mechanical delivery. Curr Opin Biotechnol 2008;19
(5):506–10.
[159] Sharei A, Zoldan J, Adamo A, Sim WY, Cho N, Jackson E, Mao S, Schneider S, Han M-J, Lytton-
Jean A. A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci 2013;110
(6):2082–7.
[160] Han X, Liu Z, Chan Jo M, Zhang K, Li Y, Zeng Z, Li N, Zu Y, Qin L. CRISPR-Cas9 delivery to
hard-to-transfect cells via membrane deformation. Sci Adv 2015;1(7), e1500454.
[161] Han X, Liu Z, Ma Y, Zhang K, Qin L. Cas9 ribonucleoprotein delivery via microfluidic cell-
deformation chip for human T-cell genome editing and immunotherapy. Adv Biosyst 2017;1
(1–2):1600007.
[162] McNeil PL, Steinhardt RA. Plasma membrane disruption: repair, prevention, adaptation. Annu Rev
Cell Dev Biol 2003;19(1):697–731.
[163] Edward JT. Molecular volumes and the stokes-Einstein equation. J Chem Educ 1970;47(4):261.
[164] Liu X, Zhao Y. CRISPR/Cas9 genome editing: fueling the revolution in cancer immunotherapy.
Curr Res Transl Med 2018;66(2):39–42.
[165] Ren J, Liu X, Fang C, Jiang S, June CH, Zhao Y. Multiplex genome editing to generate universal
CAR T cells resistant to PD1 inhibition. Clin Cancer Res 2017;23(9):2255–66.
[166] Wu Y-C, Wu T-H, Clemens DL, Lee B-Y, Wen X, Horwitz MA, Teitell MA, Chiou P-Y. Mas-
sively parallel delivery of large cargo into mammalian cells with light pulses. Nat Methods 2015;12
(5):439.
[167] Kang W, Giraldo-Vela JP, Nathamgari SSP, McGuire T, McNaughton RL, Kessler JA, Espinosa HD.
Microfluidic device for stem cell differentiation and localized electroporation of postmitotic neurons.
Lab Chip 2014;14(23):4486–95.
[168] Boukany PE, Morss A, Liao W-C, Henslee B, Jung H, Zhang X, Yu B, Wang X, Wu Y, Li L, Gao K,
Hu X, Zhao X, Hemminger O, Lu W, Lafyatis GP, Lee LJ. Nanochannel electroporation delivers
precise amounts of biomolecules into living cells. Nat Nanotechnol 2011;6(11):747–54.
[169] Gao K, Li L, He L, Hinkle K, Wu Y, Ma J, Chang L, Zhao X, Perez DG, Eckardt S. Design of a
microchannel-nanochannel-microchannel array based nanoelectroporation system for precise gene
transfection. Small 2014;10(5):1015–23.
[170] Chang L, Gallego-Perez D, Zhao X, Bertani P, Yang Z, Chiang C-L, Malkoc V, Shi J, Sen CK,
Odonnell L. Dielectrophoresis-assisted 3D nanoelectroporation for non-viral cell transfection in
adoptive immunotherapy. Lab Chip 2015;15(15):3147–53.
[171] Desalvo A, Bateman F, James E, Morgan H, Elliott T. Time-resolved microwell cell-pairing array
reveals multiple T cell activation profiles. Lab Chip 2020;20(20):3772–83.
[172] Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol
2013;31:443–73.
[173] Gough A, Stern AM, Maier J, Lezon T, Shun T-Y, Chennubhotla C, Schurdak ME, Haney SA, Tay-
lor DL. Biologically relevant heterogeneity: metrics and practical insights. Slas Discov Adv Life Sci
R&D 2017;22(3):213–37.
[174] Mashouri L, Yousefi H, Aref AR, Mohammad Ahadi A, Molaei F, Alahari SK. Exosomes: compo-
sition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer 2019;18
(1):75.
[175] Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier
B, Le Chevalier T. Malignant effusions and immunogenic tumour-derived exosomes. Lancet
2002;360(9329):295–305.
[176] Diamond JM, Vanpouille-Box C, Spada S, Rudqvist N-P, Chapman JR, Ueberheide BM, Pilones
KA, Sarfraz Y, Formenti SC, Demaria S. Exosomes shuttle TREX1-sensitive IFN-stimulatory
dsDNA from irradiated cancer cells to DCs. Cancer Immunol Res 2018;6(8):910–20.
[177] You
B, Xu W, Zhang B. Engineering exosomes: a new direction for anticancer treatment. Am
J Cancer Res 2018;8(8):1332.
[178] Zhu Q, Heon M, Zhao Z, He M. Microfluidic engineering of exosomes: editing cellular messages for
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
precision therapeutics. Lab Chip 2018;18(12):1690–703.
[179] Li Q, Huang Q, Huyan T, Wang Y, Huang Q, Shi J. Bifacial effects of engineering tumour cell-
derived exosomes on human natural killer cells. Exp Cell Res 2018;363(2):141–50.
[180] Aryani A, Denecke B. Exosomes as a nanodelivery system: a key to the future of neuromedicine? Mol
Neurobiol 2016;53(2):818–34.
[181] Chaput N, Taı¨eb J, Schartz NE, Andre F, Angevin E, Zitvogel L. Exosome-based immunotherapy.
Cancer Immunol Immunother 2004;53(3):234–9.
[182] Kim S-M, Kim H-S. Engineering of extracellular vesicles as drug delivery vehicles. Stem Cell Investig
2017;4:74.
[183] Jo W, Jeong D, Kim J, Cho S, Jang SC, Han C, Kang JY, Gho YS, Park J. Microfluidic fabrication of
cell-derived nanovesicles as endogenous RNA carriers. Lab Chip 2014;14(7):1261–9.
[184] Barani H, Montazer M. A review on applications of liposomes in textile processing. J Liposome Res
2008;18(3):249–62.
[185] Atilgan E, Sun SX. Shape transitions in lipid membranes and protein mediated vesicle fusion and fis-
sion. J Chem Phys 2007;126(9), 03B604.
[186] Majzoub RN, Ewert KK, Safinya CR. Cationic liposome–nucleic acid nanoparticle assemblies with
applications in gene delivery and gene silencing. Philos Trans R Soc A Math Phys Eng Sci 2016;374
(2072), 20150129.
[187] Yoon J, Jo W, Jeong D, Kim J, Jeong H, Park J. Generation of nanovesicles with sliced cellular mem-
brane fragments for exogenous material delivery. Biomaterials 2015;59:12–20.
[188] Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell
culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;30(1). 3.22.1–3.22.29.
[189] Jo W, Kim J, Yoon J, Jeong D, Cho S, Jeong H, Yoon Y, Kim S, Gho Y, Park J. Large-scale gen-
eration of cell-derived nanovesicles. Nanoscale 2014;6(20):12056–64.
[190] Zhao Z, McGill J, Gamero-Kubota P, He M. Microfluidic on-demand engineering of exosomes
towards cancer immunotherapy. Lab Chip 2019;19(10):1877–86.
[191] Gong J, Koido S, Calderwood SK. Cell fusion: from hybridoma to dendritic cell-based vaccine.
Expert Rev Vaccines 2008;7(7):1055–68.
[192] Rosenblatt J, Kufe D, Avigan D. Dendritic cell fusion vaccines for cancer immunotherapy. Expert
Opin Biol Ther 2005;5(5):703–15.
[193] Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012;12
(4):265–77.
[194] Harari A, Graciotti M, Bassani-Sternberg M, Kandalaft LE. Antitumour dendritic cell vaccination in a
priming and boosting approach. Nat Rev Drug Discov 2020;19(9):635–52.
[195] Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by immunization with
fusions of dendritic and carcinoma cells. Nat Med 1997;3(5):558–61.
[196] Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y, Cannistra S, Avigan D, Kufe D. Fusions of
human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 2000;165(3):1705–11.
[197] Rosenblatt J, Vasir B, Uhl L, Blotta S, MacNamara C, Somaiya P, Wu Z, Joyce R, Levine JD, Domb-
agoda D. Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor
immune responses in patients with multiple myeloma. Blood 2011;117(2):393–402.
[198] Yang
[199] Skelley AM, Kirak O, Suh H, Jaenisch R, Voldman J. Microfluidic control of cell pairing and fusion.
[200] Dura B, Liu Y, Voldman J. Deformability-based microfluidic cell pairing and fusion. Lab Chip
[201] Lin C-H, Hsiao Y-H, Chang H-C, Yeh C-F, He C-K, Salm EM, Chen C, Chiu M, Hsu C-H.
[202] Lu Y-T, Pendharkar GP, Lu C-H, Chang C-M, Liu C-H. A microfluidic approach towards hybrid-
[203] Laydon DJ, Bangham CR, Asquith B. Estimating T-cell repertoire diversity: limitations of classical
J, Shen MH. Polyethylene glycol-mediated cell fusion. Method Mol Biol 2006;325:59–66.
Nat Methods 2009;6(2):147–52.
2014;14(15):2783–90.
A microfluidic dual-well device for high-throughput single-cell capture and culture. Lab Chip
2015;15(14):2928–38.
oma generation for cancer immunotherapy. Oncotarget 2015;6(36):38764.
estimators and a new approach. Philos Trans R Soc B Biol Sci 2015;370(1675):20140291.
193Tumor-on-a-chip devices for cancer immunotherapy
194 Xuan Mu and Yu Shrike Zhang
[204] Han A, Glanville J, Hansmann L, Davis MM. Linking T-cell receptor sequence to functional pheno-
type at the single-cell level. Nat Biotechnol 2014;32(7):684–92.
[205] Kitaura K, Shini T, Matsutani T, Suzuki R. A new high-throughput sequencing method for deter-
mining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential
new invariant TCR α chains. BMC Immunol 2016;17(1):38.
[206] Shembekar N, Chaipan C, Utharala R, Merten CA. Droplet-based microfluidics in drug discovery,
transcriptomics and high-throughput molecular genetics. Lab Chip 2016;16(8):1314–31.
[207] Zhang K, Liang QL, Ma S, Mu XA, Hu P, Wang YM, Luo GA. On-chip manipulation of continuous
picoliter-volume superparamagnetic droplets using a magnetic force. Lab Chip 2009;9(20):2992–9.
[208] Segaliny AI, Li G, Kong L, Ren C, Chen X, Wang JK, Baltimore D, Wu G, Zhao W. Functional
TCR T cell screening using single-cell droplet microfluidics. Lab Chip 2018;18(24):3733–49.
[209] Bounab Y, Eyer K, Dixneuf S, Rybczynska M, Chauvel C, Mistretta M, Tran T, Aymerich N,
Chenon G, Llitjos J-F. Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap. Nat Protoc 2020;15(9):2920–55.
[210] Ng AH, Peng S, Xu AM, Noh WJ, Guo K, Bethune MT, Chour W, Choi J, Yang S, Baltimore D.
MATE-Seq: microfluidic antigen-TCR engagement sequencing. Lab Chip 2019;19(18):3011–21.
[211] Labanieh L, Nguyen TN, Zhao W, Kang D-K. Floating droplet array: an ultrahigh-throughput device
for droplet trapping, real-time analysis and recovery. Micromachines 2015;6(10):1469–82.
[212] Park S-Y, Wu T-H, Chen Y, Teitell MA, Chiou P-Y. High-speed droplet generation on demand
driven by pulse laser-induced cavitation. Lab Chip 2011;11(6):1010–2.
[213] Huang LR, Cox EC, Austin RH, Sturm JC. Continuous particle separation through deterministic
lateral displacement. Science 2004;304(5673):987–90.
[214] Inglis DW, Davis JA, Austin RH, Sturm JC. Critical particle size for fractionation by deterministic
lateral displacement. Lab Chip 2006;6(5):655–8.
[215] Andersen RS, Kvistborg P, Frøsig TM, Pedersen NW, Lyngaa R, Bakker AH, Shu CJ, Thor Straten
P, Schumacher TN, Hadrup SR. Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers. Nat Protoc 2012;7(5):891–902.
[216] Lin WY, Gong Q, Seshasayee D, Lin Z, Ou Q, Ye S, Suto E, Shu J, Pun Lee W, Lee C-WV, Fuh G,
Leabman M, Iyer S, Howell K, Gelzleichter T, Beyer J, Danilenko D, Yeh S, DeForge LE, Ebens A,
Thompson JS, Ambrose C, Balazs M, Starovasnik MA, Martin F. Anti-BR3 antibodies: a new class of
B-cell immunotherapy combining cellular depletion and survival blockade. Blood 2007;110
(12):3959–67.
[217] Gong Q, Ou Q, Ye S, Lee WP, Cornelius J, Diehl L, Lin WY, Hu Z, Lu Y, Chen Y. Importance of
cellular microenvironment and circulatory dynamics in B cell immunotherapy. J Immunol 2005;174
(2):817–26.
[218] Li J, Sai T, Berger M, Chao Q, Davidson D, Deshmukh G, Drozdowski B, Ebel W, Harley S, Henry
M. Human antibodies for immunotherapy development generated via a human B cell hybridoma
technology. Proc Natl Acad Sci 2006;103(10):3557–62.
[219] Weiner LM, Murray JC, Shuptrine CW. Antibody-based immunotherapy of cancer. Cell 2012;148
(6):1081–4.
[220] Eyer K, Doineau RC, Castrillon CE, Brisen˜o-Roa L, Menrath V, Mottet G, England P, Godina A,
Brient-Litzler E, Nizak C. Single-cell deep phenotyping of IgG-secreting cells for high-resolution
immune monitoring. Nat Biotechnol 2017;35(10):977.
[221] Mazutis L, Gilbert J, Ung WL, Weitz DA, Griffiths AD, Heyman JA. Single-cell analysis and sorting
using droplet-based microfluidics. Nat Protoc 2013;8(5):870–91.
[222]
Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, D€orner
T, Hiepe F. Competence
and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006;6
(10):741–50.
[223] Lavinder JJ, Wine Y, Giesecke C, Ippolito GC, Horton AP, Lungu OI, Hoi KH, DeKosky BJ, Murrin
EM, Wirth MM. Identification and characterization of the constituent human serum antibodies
elicited by vaccination. Proc Natl Acad Sci 2014;111(6):2259–64.
[224] Di Carlo D. Inertial microfluidics. Lab Chip 2009;9(21):3038–46.
[225] Warkiani ME, Guan G, Luan KB, Lee WC, Bhagat AAS, Kant Chaudhuri P, Tan DS-W, Lim WT,
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Lee SC, Chen PCY, Lim CT, Han J. Slanted spiral microfluidics for the ultra-fast, label-free isolation
of circulating tumor cells. Lab Chip 2014;14(1):128–37.
[226] Ryu H, Choi K, Qu Y, Kwon T, Lee JS, Han J. Patient-derived airway secretion dissociation tech-
nique to isolate and concentrate immune cells using closed-loop inertial microfluidics. Anal Chem
2017;89(10):5549–56.
[227] Martel JM, Smith KC, Dlamini M, Pletcher K, Yang J, Karabacak M, Haber DA, Kapur R, Toner M.
Continuous flow microfluidic bioparticle concentrator. Sci Rep 2015;5:11300.
[228] Yu ZTF, Joseph JG, Liu SX, Cheung MK, Haffey PJ, Kurabayashi K, Fu J. Centrifugal microfluidics
for sorting immune cells from whole blood. Sens Actuators B 2017;245:1050–61.
195Tumor-on-a-chip devices for cancer immunotherapy
Соседние файлы в папке Библиотека им академика М.И. Перельмана